MedPath
HSA Approval

Zepilen Powder for Injection 1g/vial

SIN14304P

Zepilen Powder for Injection 1g/vial

Zepilen Powder for Injection 1g/vial

January 31, 2013

MEDOCHEMIE SINGAPORE PTE. LTD.

MEDOCHEMIE SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantMEDOCHEMIE SINGAPORE PTE. LTD.
Licence HolderMEDOCHEMIE SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, POWDER, FOR SOLUTION

INTRAVENOUS, INTRAMUSCULAR

Medical Information

J01DB04

cefazolin

Manufacturer Information

MEDOCHEMIE SINGAPORE PTE. LTD.

Medochemie Ltd - Factory C

MEDOCHEMIE (FAR EAST) LTD., (ASEPTIC CEPHALOSPORIN FACILITY)

Active Ingredients

Cefazolin sodium 1048mg eqv. Cefazolin (sterile)

1000 mg

Cefazolin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Zepilen Powder for Injection 1g/vial - HSA Approval | MedPath